Cooley

Tony Guan

Deals
5
Latest
May 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 5 deals
Deals by year
Tony Guan: deals by year0520252026 YTD: 5 M&A52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Tony Guan was named on, most recent first
May 2026 Vaccine Company –LillyAcquisitionLegal adviser to Vaccine Company (target)Announced1,550.0Biotech+1Lilly acquisition of Vaccine Company
May 2026 Engage Bio –Eli LillyAcquisitionLegal adviser to Engage Bio (target)Announced202.0Biotech+1Eli Lilly acquisition of Engage Bio
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Ajax Therapeutics (target)Announced2,300.0Biotech+2Eli Lilly and Company acquisition of Ajax Therapeutics
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionLegal adviser to CrossBridge Bio (target)Announced300.0Biotech+2Eli Lilly and Company acquisition of CrossBridge Bio
Mar 2026 PFF enterprise (B2B) business Pro Football FocusTeamworksAsset saleLegal adviser to Pro Football Focus (seller)Announced–Data & AnalyticsTeamworks acquisition of PFF enterprise (B2B) business

Deals where Tony Guan is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.